Menu
Recruiting NCT07081100

Probiotics and Non-Organic Gastrointestinal Improvement

No phase Interventional Gastrointestinal Function

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Probiotic group.
Who it may be relevant to
Registry conditions: Gastrointestinal Function. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Study on the Effect of Probiotics on Improving Gastrointestinal Function in Patients With Non-organic Gastrointestinal Dysfunction

Overview

To verify the improvement of gastrointestinal function in patients with non-organic gastrointestinal dysfunction after 4 weeks of intervention with compound probiotics.

Interventions

  • Dietary supplement Probiotic group
    Participants took a freeze-dried probiotic powder every day, half an hour after a meal.

Primary outcome measures

  • Improvement of gastrointestinal function in study participants [Time frame: 4 weeks]

Eligibility criteria

Inclusion criteria

  • Voluntarily sign the informed consent form and agree to participate in the study.
  • Ability to complete the study according to the trial protocol requirements.
  • Aged 18-65 years.
  • Clinical diagnosis of non-organic gastrointestinal dysfunction (e.g., functional dyspepsia, functional constipation) without other serious organic diseases.

Exclusion criteria

  • Use of drugs affecting intestinal flora (antibiotics, probiotics, intestinal mucosal protectants, herbal medicines, etc.) for >1 week within 1 month prior to screening.
  • Short-term use of products with functions similar to the investigational product, which may interfere with result interpretation.
  • Antibiotic use during the study period.
  • History of severe systemic diseases or malignancies.
  • Allergy to any ingredient in the compound probiotic freeze-dried powder used in the trial.
  • Pregnancy, lactation, or plans for pregnancy in the near future.
  • Inability to participate due to personal reasons.
  • Other conditions deemed unsuitable by the investigators.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

China · 1 center
  • Suzhou Ninth People's Hospital Suzhou Ninth Hospital affiliated to Soochow University — Suzhou

Identifiers

NCT: NCT07081100 · WK20250716

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗